THC Farmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Jun '15 Jun 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012	Sep '11 Sep 30, 2011	Sep '10 Sep 30, 2010
Revenue	0.02	0.02	0.02	0.03	0.03	0.04
Revenue Growth (YoY)	-1.50%	-12.04%	-29.23%	-10.48%	-10.55%	-4.80%
Cost of Revenue	0.01	0.01	0.02	0.02	0.01	0.01
Gross Profit	0	0.01	0	0.01	0.02	0.03
Selling, General & Admin	0.07	0.03	0.02	0.04	0.04	0.02
Operating Expenses	0.07	0.03	0.02	0.04	0.05	0.03
Operating Income	-0.07	-0.02	-0.02	-0.02	-0.02	0
Interest Expense	-0	-0.01	-0	-0	-0	-0
EBT Excluding Unusual Items	-0.07	-0.03	-0.02	-0.03	-0.03	-0
Gain (Loss) on Sale of Assets	-	-	-	-0	-	-0
Asset Writedown	-	-	-	-0.01	-	-0.01
Pretax Income	-0.07	-0.03	-0.02	-0.04	-0.03	-0.01
Net Income	-0.07	-0.03	-0.02	-0.04	-0.03	-0.01
Net Income to Common	-0.07	-0.03	-0.02	-0.04	-0.03	-0.01
Shares Outstanding (Basic)	13	9	9	9	9	5
Shares Outstanding (Diluted)	13	9	9	9	9	5
Shares Change (YoY)	50.42%	-	-	-	69.35%	2.08%
EPS (Basic)	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.01	-0.00	-0.00	-0.00	-0.00	-0.00
Free Cash Flow	-1.51	-0.02	-0.02	-0.02	0.02	0
Free Cash Flow Per Share	-0.11	-0.00	-0.00	-0.00	0.00	0.00
Gross Margin	23.86%	35.38%	22.37%	45.06%	64.32%	68.58%
Operating Margin	-378.15%	-126.18%	-90.50%	-76.96%	-69.52%	1.56%
Profit Margin	-391.34%	-161.27%	-110.15%	-129.80%	-83.02%	-28.18%
Free Cash Flow Margin	-8146.50%	-99.31%	-88.78%	-72.69%	60.22%	7.99%
EBITDA	-0.07	-0.02	-0.02	-0.02	-0.02	0
EBITDA Margin	-	-123.03%	-85.66%	-72.30%	-50.60%	6.57%
D&A For EBITDA	0	0	0	0	0.01	0
EBIT	-0.07	-0.02	-0.02	-0.02	-0.02	0
EBIT Margin	-	-126.18%	-90.50%	-76.96%	-69.52%	1.56%
Revenue as Reported	0.02	0.02	0.02	0.03	0.03	0.04